About: Neurizon Therapeutics Limited, a clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia. Its lead candidate is NUZ-001, a small molecule drug designed to support cellular protein homeostasis which is evaluated in Regimen I of the Phase 2/3 HEALEY ALS platform trial for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.06 (-6.45%)
NUZ ASX Neurizon Therapeutics Ltd
Neurizon Therapeutics Ltd share price
NUZ price activity
Last Price
$0.060
Change (24hr)
-0.00 AUD (6.45%)
Volume
283.75K
Volume (4w avg)
-
Open
$0.06
Day Range
$0.06 - $0.06
Previous Close
$0.06
Last Trade
20 Nov, 4:54 am GMT+0
Delayed
20 Nov, 4:54 am GMT+0
NUZ price performance
Delayed
20 Nov, 4:54 am GMT+0
NUZ details
NUZ Market Signals